If you’ve been following the headlines, GLP-1 drugs (and next-gen cousins) are the medical story of the moment — and with good reason. They’re reshaping how clinicians treat obesity and causing major shifts in pharmaceutical markets. Here’s a plain-spoken rundown of how they work, what the best trials show, safety considerations, market context, and what it means if you or someone you care about is thinking about treatment.
